A study carried out in Brazil published in 2016 reported AAT levels in 926 patients with COPD; they calculated an AATD prevalence of 2.8%, while the prevalence of the ZZ genotype, which corresponds to a severe AATD, was 0.8% [18]. This evidence concerns the gene SERPINA1 and alpha 1-antitrypsin deficiency.